Detalhe da pesquisa
1.
Antibodies to human neutrophil antigen HNA-3b implicated in cases of neonatal alloimmune neutropenia.
Transfusion
; 58(5): 1264-1270, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451309
2.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance.
Hematol Transfus Cell Ther
; 46 Suppl 1: S67-S71, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604928
3.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Antifibrinolytics.
Hematol Transfus Cell Ther
; 46 Suppl 1: S40-S47, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555249
4.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Inadvertent intraoperative hypothermia.
Hematol Transfus Cell Ther
; 46 Suppl 1: S53-S59, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38580496
5.
Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia.
Hematol Transfus Cell Ther
; 45(3): 338-341, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35882618
6.
Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system.
Hematol Transfus Cell Ther
; 44(3): 374-378, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741301
7.
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy.
Hematol Transfus Cell Ther
; 44(2): 206-212, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35071990
8.
Association of preoperative anemia and increased risk of blood transfusion and length of hospital stay in adults undergoing hip and knee arthroplasty: An observational study in a single tertiary center.
Health Sci Rep
; 4(4): e448, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34938895
9.
Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system
Hematol., Transfus. Cell Ther. (Impr.)
; 44(3): 374-378, July-Sept. 2022. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1405005
10.
SARS-COV-2: is it a risk for blood transfusion?
Hematol Transfus Cell Ther
; 44(1): 100-103, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485826
11.
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy
Hematol., Transfus. Cell Ther. (Impr.)
; 44(2): 206-212, Apr.-June 2022. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1385048
12.
COVID-19 convalescent plasma transfusion.
Hematol Transfus Cell Ther
; 42(2): 113-115, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313872
13.
Guidelines on transfusion of red blood cells: Prognosis of patients who decline blood transfusions.
Hematol Transfus Cell Ther
; 40(4): 377-381, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370417
14.
SARS-COV-2: is it a risk for blood transfusion?
Hematol., Transfus. Cell Ther. (Impr.)
; 44(1): 100-103, Jan.-Mar. 2022. ilus
Artigo
em Inglês
| LILACS | ID: biblio-1364885
15.
Alloimmunization screening after transfusion of red blood cells in a prospective study.
Rev Bras Hematol Hemoter
; 34(3): 206-11, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23049421
16.
Alloimmunization screening after transfusion of red blood cells in a prospective study
Rev. bras. hematol. hemoter
; 34(3): 206-211, 2012. graf, tab
Artigo
em Inglês
| LILACS | ID: lil-640869